Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling
Blood · 23.02.2023 · 141 (8) · 886-903
DOI: 10.1182/blood.2022016835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 23.02.2023. Verfasst von Francisco Caiado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich, Zurich, Switz…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Dioxygenases. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Clonal hematopoiesis of indeterminate potential (CHIP), also referred to as aging-related clonal hematopoiesis, is defined as an asymptomatic clonal expansion of mutant mature hematopoietic cells in ≥4% of blood leukocytes. CHIP associates with advanced age and increased risk for hematological malignancy, cardiovascular disease, and all-cause mortality. Loss-of-function somatic mutations in TET2 are frequent drivers of CHIP. However, the contribution of aging-associated cooperating cell-extrinsic drivers, like inflammation, remains underexplored. Using bone marrow (BM) transplantation and newly developed genetic mosaicism (HSC-SCL-Cre-ERT; Tet2+/flox; R26+/tm6[CAG-ZsGreen1]Hze) mouse models of Tet2+/−driven CHIP, we observed an association between increased Tet2+/− clonal expansion and higher BM levels of the inflammatory cytokine interleukin-1 (IL-1) upon aging. Administration of IL-1 to mice carrying CHIP led to an IL-1 receptor 1 (IL-1R1)–dependent expansion of Tet2+/− hematopoietic stem and progenitor cells (HSPCs) and mature blood cells. This expansion was caused by increased Tet2+/− HSPC cell cycle progression, increased multilineage differentiation, and higher repopulation capacity compared with their wild-type counterparts. In agreement, IL-1α–treated Tet2+/− hematopoietic stem cells showed increased DNA replication and repair transcriptomic signatures and reduced susceptibility to IL-1α–mediated downregulation of self-renewal genes. More important, genetic deletion of IL-1R1 in Tet2+/− HPSCs or pharmacologic inhibition of IL-1 signaling impaired Tet2+/− clonal expansion, establishing the IL-1 pathway as a relevant and therapeutically targetable driver of Tet2+/− CHIP progression during aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich, Zurich, Switzerland.
ORCID-Profile: Francisco Caiado, Larisa V Kovtonyuk, Steffen Boettcher, Markus G Manz
Zitieren
APA
Caiado, F., Kovtonyuk, L. V., Gonullu, N. G., Fullin, J., Boettcher, S., & Manz, M. G. (2023). Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling. Blood, 141(8), 886-903. https://doi.org/10.1182/blood.2022016835
Vancouver
Caiado F, Kovtonyuk LV, Gonullu NG, Fullin J, Boettcher S, Manz MG. Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling. Blood. 2023;141(8):886-903. doi:10.1182/blood.2022016835
BibTeX
@article{Caiado2023,
author = {Caiado, Francisco and Kovtonyuk, Larisa V and Gonullu, Nagihan G and Fullin, Jonas and Boettcher, Steffen and Manz, Markus G},
title = {Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling},
journal = {Blood},
year = {2023},
volume = {141},
number = {8},
pages = {886--903},
doi = {10.1182/blood.2022016835}
}
EUVIMED